Strategies towards in vivo imaging of active transglutaminase type 2 using positron emission tomography

Transglutaminase type 2 (TG2) is increasingly linked to the pathogenesis of several diseases, such as celiac disease, cancer, and fibrotic and neurodegenerative diseases. In parallel with becoming an attractive target for therapy, interest in the development of compounds for in vivo imaging of TG2 i...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Wildt, Berend, Lammertsma, Adriaan A., Drukarch, Benjamin, Windhorst, Albert D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332496/
https://www.ncbi.nlm.nih.gov/pubmed/27380031
http://dx.doi.org/10.1007/s00726-016-2288-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332496/
https://www.ncbi.nlm.nih.gov/pubmed/27380031
http://dx.doi.org/10.1007/s00726-016-2288-y

Ejemplares similares